- Home
- FUFU vs BBNX Comparison
FUFU vs BBNX Comparison
Compare FUFU & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUFU
- BBNX
- Stock Information
- Founded
- FUFU 2020
- BBNX 2015
- Country
- FUFU Singapore
- BBNX United States
- Employees
- FUFU N/A
- BBNX N/A
- Industry
- FUFU
- BBNX Medical/Dental Instruments
- Sector
- FUFU
- BBNX Health Care
- Exchange
- FUFU NYSE
- BBNX Nasdaq
- Market Cap
- FUFU 576.7M
- BBNX 649.9M
- IPO Year
- FUFU N/A
- BBNX 2025
- Fundamental
- Price
- FUFU $3.44
- BBNX $13.52
- Analyst Decision
- FUFU Buy
- BBNX Strong Buy
- Analyst Count
- FUFU 2
- BBNX 10
- Target Price
- FUFU $6.25
- BBNX $25.20
- AVG Volume (30 Days)
- FUFU 455.7K
- BBNX 526.7K
- Earning Date
- FUFU 08-19-2025
- BBNX 07-29-2025
- Dividend Yield
- FUFU N/A
- BBNX N/A
- EPS Growth
- FUFU N/A
- BBNX N/A
- EPS
- FUFU 0.01
- BBNX N/A
- Revenue
- FUFU $396,963,000.00
- BBNX $69,830,000.00
- Revenue This Year
- FUFU $4.17
- BBNX $32.79
- Revenue Next Year
- FUFU $59.54
- BBNX $36.59
- P/E Ratio
- FUFU $314.69
- BBNX N/A
- Revenue Growth
- FUFU 7.13
- BBNX 38911.17
- 52 Week Low
- FUFU $2.91
- BBNX $8.89
- 52 Week High
- FUFU $6.33
- BBNX $24.50
- Technical
- Relative Strength Index (RSI)
- FUFU 53.15
- BBNX N/A
- Support Level
- FUFU $2.96
- BBNX N/A
- Resistance Level
- FUFU $3.38
- BBNX N/A
- Average True Range (ATR)
- FUFU 0.21
- BBNX 0.00
- MACD
- FUFU 0.04
- BBNX 0.00
- Stochastic Oscillator
- FUFU 89.83
- BBNX 0.00
About FUFU BITFUFU INC
BitFuFu Inc is a digital asset mining and cloud-mining service provider that fosters a secure, compliant, and transparent blockchain infrastructure. It provides stable and intelligent digital asset mining solutions, including one-stop cloud-mining services and miner hosting services to institutional customers and individual digital assets. The company generates the majority of its revenue from the sale of cloud-mining solutions, followed by Self-mining revenue. Geographically, the company generates revenue from North America, Asia, Europe, and Others.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.